Effect of 5-HT2 receptor antagonists on a cranial nerve reflex in the rabbit:: evidence for inverse agonism

被引:26
作者
Harvey, JA [1 ]
Welsh, SE [1 ]
Hood, H [1 ]
Romano, AG [1 ]
机构
[1] Allegheny Univ Hlth Sci, Dept Pharmacol, Div Behav Neurobiol, Philadelphia, PA 19129 USA
关键词
ritanserin; MDL-11,939; mianserin; ketanserin; BOL; LY-53,857; 5-HT(2A/2C) receptor; antagonists; nictitating membrane; motor performance; rabbit;
D O I
10.1007/s002130050820
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study examined the role of the serotonin 5-HT(2) receptor in motor function by examining the effect of antagonists on the motor performance of a cranial nerve reflex, the nictitating membrane (NM) rifler of the rabbit. The NM reflex was elicited by varying intensities of a tactile stimulus and the magnitudes of the elicited responses were measured at each intensity. Dose-response curves were obtained for the effects of several 5-HT2 receptor antagonists on response magnitude. d-Bromolysergic acid diethylamide (BOL), LY-53,857 and ketanserin had no significant effect on the magnitude of the NM reflex, indicating that they are neutral antagonists. However, the 5-HT(2) receptor antagonists ritanserin, MDL 11,939 and mianserin produced a significant reduction in response magnitude with no significant effects on response frequency, suggesting that they were acting as inverse agonists at the 5-HT(2) receptor. The reduction in reflex magnitude produced by mianserin (10 mu mol/kg) was fully blocked by BOL (5.8 mu mol/kg), supporting the conclusion that mianserin was producing a reduction in reflex magnitude through an effect at the 5-HT2 receptor. The occurrence of inverse agonism suggests the possible existence of constitutive activity in vivo. We conclude that the 5-HT(2) receptor (either 2A or 2C) plays an important role in motor function, perhaps by providing a tonic influence on motor systems.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 34 条
[31]   Effects of serotonin 5-HT2A/2C antagonists on associative learning in the rabbit [J].
Welsh, SE ;
Romano, AG ;
Harvey, JA .
PSYCHOPHARMACOLOGY, 1998, 137 (02) :157-163
[32]  
WESTPHAL RS, 1994, MOL PHARMACOL, V46, P937
[33]  
WIKLUND L, 1981, J PHYSIOL-PARIS, V77, P183
[34]  
YAMAMOTO T, 1991, J PHARMACOL EXP THER, V258, P999